The Max Delbrück Center (MDC) for Molecular Medicine in Berlin and Cancer Research Institute at Hadassah (HCRI) convened a joint symposium highlighting collaborative European–Israeli clinical trial models, molecular oncology, and cellular therapies.
The Berlin-Jerusalem symposium, initiated and managed by Dr. Yoni Arnon, a physician-researcher at the Sharett Institute of Oncology and the Cancer Research Institute at Hadassah. Dr. Yoni Arnon is currently on a fellowship at — Institute of Tumor Immunology Charité – Universitätsmedizin Berlin“
